Antiretroviral treatment of HIV-2 infection

Saraswathi Nk, Babu Pg, Devapriya F, John Tj, The detection of HIV-2 infection in southern India. Indian Journal of Medical Research. ,vol. 97, pp. 49- 52 ,(1993)

David A Margolis, Cynthia C Brinson, Graham H R Smith, Jerome de Vente, Debbie P Hagins, Joseph J Eron, Sandy K Griffith, Marty H St Clair, Marita C Stevens, Peter E Williams, Susan L Ford, Britt S Stancil, Melinda M Bomar, Krischan J Hudson, Kimberly Y Smith, William R Spreen, Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial Lancet Infectious Diseases. ,vol. 15, pp. 1145- 1155 ,(2015) , 10.1016/S1473-3099(15)00152-8

Helen R. Fryer, Carla Van Tienen, Maarten Schim Van Der Loeff, Peter Aaby, Zacarias J. Da Silva, Hilton Whittle, Sarah L. Rowland-Jones, Thushan I. de Silva, Predicting the extinction of HIV-2 in rural Guinea-Bissau AIDS. ,vol. 29, pp. 2479- 2486 ,(2015) , 10.1097/QAD.0000000000000844

Benoit Visseaux, Charlotte Charpentier, Gilles Collin, Mélanie Bertine, Gilles Peytavin, Florence Damond, Sophie Matheron, Eric Lefebvre, Françoise Brun-Vézinet, Diane Descamps, ANRS CO5 HIV-2 Cohort, None, Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates PLOS ONE. ,vol. 10, pp. e0134904- ,(2015) , 10.1371/JOURNAL.PONE.0134904

Ricardo Jorge Camacho, Special Aspects of the Treatment of HIV-2-Infected Patients Intervirology. ,vol. 55, pp. 179- 183 ,(2012) , 10.1159/000332025

Sophie Matheron, Sophie Pueyo, Florence Damond, François Simon, Annie Leprêtre, Pauline Campa, Roger Salamon, Genevieve Chêne, Françoise Brun-Vezinet, French HIV-2 Cohort Study Group, Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort. AIDS. ,vol. 17, pp. 2593- 2601 ,(2003) , 10.1097/00002030-200312050-00006

Kristen Andreatta, Michael D Miller, Kirsten L White, None, HIV-2 antiviral potency and selection of drug resistance mutations by the integrase strand transfer inhibitor elvitegravir and NRTIs emtricitabine and tenofovir in vitro. Journal of Acquired Immune Deficiency Syndromes. ,vol. 62, pp. 367- 374 ,(2013) , 10.1097/QAI.0B013E31827B55F1

B. Visseaux, M. Hurtado-Nedelec, C. Charpentier, G. Collin, A. Storto, S. Matheron, L. Larrouy, F. Damond, F. Brun-Vezinet, D. Descamps, , Molecular Determinants of HIV-2 R5–X4 Tropism in the V3 Loop: Development of a New Genotypic Tool The Journal of Infectious Diseases. ,vol. 205, pp. 111- 120 ,(2012) , 10.1093/INFDIS/JIR698

Luis Menéndez-Arias, Mar Álvarez, Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection Antiviral Research. ,vol. 102, pp. 70- 86 ,(2014) , 10.1016/J.ANTIVIRAL.2013.12.001

Carla van Tienen, Maarten Schim van der Loeff, Ingrid Peterson, Matthew Cotten, Sören Andersson, Birgitta Holmgren, Tim Vincent, Thushan de Silva, Sarah Rowland-Jones, Peter Aaby, Hilton Whittle, HTLV-1 and HIV-2 infection are associated with increased mortality in a rural west African community. PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0029026